In recent years, due to a lack of an effective vaccine, effective prophylactic strategies for toxoplasmosis, especially in pregnant women and/or immunocompromised patients with a CD4 < 100 cells/μl, have been strongly recommended (Dubey et al., 2012). The gene discussed is CD4; the disease is toxoplasmosis.